title: [Changes of the hemostasis system in patients with obturation jaundice caused by choledocholithiasis, and possibilities of their correction with the help of miniinvasive operative interventions].
abstract: Changes in the hemostasis system in choledocholithiasis, taking into account the obturation jaundice severity and possibility of the correction conduction, using miniinvasive operative interventions, were studied. Dynamic of changes in the hemostasis system in patients preoperatively, in 1 and 3 days after endoscopic papillosphincterotomy were monitored, using the method of a low--rate piezoelectric thromboelastography. Basing on analysis of the results, the changes in hemostasis in obturation jaundice were classified, taking into account its degree of severity, what have permitted to select a correct tactics for prophylaxis of hemorrhagic complications intraoperatively and postoperatively.
authors.forename: A I
authors.initials: AI
authors.lastname: Tkachenko
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D042883:Choledocholithiasis / Q000097:blood / Q000150:complications / Q000601:surgery*; D004334:Drug Administration Schedule; D006487:Hemostasis / Q000187:drug effects / Q000502:physiology*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D041781:Jaundice, Obstructive / Q000097:blood / Q000209:etiology / Q000601:surgery*; D010951:Plasma Exchange; D011183:Postoperative Complications / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D012720:Severity of Illness Index; D016717:Sphincterotomy, Endoscopic; D013916:Thrombelastography; D014148:Tranexamic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D014148:Tranexamic Acid; C411345:bemiparin